Postischemic treatment by trans‐resveratrol in rat liver ischemia‐reperfusion: A possible strategy in liver surgery
Sahar Hassan‐Khabbar, Charles‐Henry Cottart, Dominique Wendum, Françoise Vibert, Jean‐Pierre Clot, Jean‐François Savouret, Marc Conti, Valérie Nivet‐Antoine – 26 March 2008 – Liver ischemia‐reperfusion (I/R) injury occurs in many clinical conditions, including liver surgery and transplantation. Oxygen free radicals generated during I/R reduce endogenous antioxidant systems and contribute to hepatic injury. trans‐Resveratrol (trans‐3,5,4′‐trihydroxystilbene) is reported to have antioxidant properties. We investigated the effect of trans‐resveratrol on liver injury induced by I/R.